PHC acquires Thermo Fisher’s anatomical pathology business for £897m
PHC Holdings has completed the acquisition of anatomical pathology business from Thermo Fisher Scientific for around $1.14bn (£897m).
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Jul 19
PHC Holdings has completed the acquisition of anatomical pathology business from Thermo Fisher Scientific for around $1.14bn (£897m).
27 Jun 19
Binah.ai, the leading provider of ready-to-use AI-powered apps, has released a series of non-invasive, video-based health and wellness…
US-based Quanterix has signed an agreement to acquire Swedish firm UmanDiagnostics in a deal valued at around $22.5m…
26 Jun 19
Soliton, announced that the company has retained Emergent Clinical Consulting, to serve as the Company's Contract Research Organization…
Molecular diagnostics firm Co-Diagnostics has announced the launch of its Logix Smart ZDC multiplex test.
ThermoGenesis, a wholly owned subsidiary of Cesca Therapeutics, announced that it has signed a strategic agreement with Cordlife…
SpeeDx, a developer of innovative molecular diagnostic solutions, has signed a collaborative agreement with GSK, to provide a…
PAVmed, a multi-product medical device company, announced that its majority owned subsidiary, Lucid Diagnostics has received the US…
24 Jun 19
Seegene has completed the FDA registration of its nucleic acid extraction instrument, the Seegene STARlet and will begin…
Bruker has introduced a new Maldi Biotyper sirius system, which can be used for novel negative-ion mode assay…